跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VISPRING 0,5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VISPRING 0,5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
VISPRING 0,5 MG/ML COLIRIO EN SOLUCION
Johnson & Johnson Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 13, 2025
Approval ID
da89c00b49eea343
Company
Johnson & Johnson Gmbh
Type
Standard
Approval Details
Approval Id
da89c00b49eea343
Drug Cima Aemps Name
VISPRING 0,5 MG/ML COLIRIO EN SOLUCION
Register Number
22025330000IP
Holder Company Name
Johnson & Johnson Gmbh
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2025-03-13
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
0,5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Sin Receta
Commercialized
No
Company Name
Johnson & Johnson Gmbh
Active Ingredients
TETRIZOLINA HIDROCLORURO
0,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 13, 2025
Approval ID
da89c00b49eea343
Type
Standard
Back to CIMA-AEMPS Approvals